Shanghai MicroPort Endovascular MedTech Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai MicroPort Endovascular MedTech has a total shareholder equity of CN¥4.1B and total debt of CN¥11.6M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥4.5B and CN¥438.5M respectively. Shanghai MicroPort Endovascular MedTech's EBIT is CN¥600.7M making its interest coverage ratio -27.9. It has cash and short-term investments of CN¥3.2B.
Key information
0.3%
Debt to equity ratio
CN¥11.56m
Debt
| Interest coverage ratio | -27.9x |
| Cash | CN¥3.18b |
| Equity | CN¥4.09b |
| Total liabilities | CN¥438.46m |
| Total assets | CN¥4.52b |
Recent financial health updates
Recent updates
These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Financial Position Analysis
Short Term Liabilities: 688016's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥360.5M).
Long Term Liabilities: 688016's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥78.0M).
Debt to Equity History and Analysis
Debt Level: 688016 has more cash than its total debt.
Reducing Debt: 688016's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: 688016's debt is well covered by operating cash flow (5632.3%).
Interest Coverage: 688016 earns more interest than it pays, so coverage of interest payments is not a concern.